Delcath Systems Announces An Independent Investigator Presentation At The Cardiovascular And Interventional Radiological Society Of Europe Annual Meeting
Portfolio Pulse from Happy Mohamed
Delcath Systems, Inc. (NASDAQ:DCTH), an interventional oncology company, announced an oral presentation by independent investigators at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Meeting. The presentation will discuss results from a retrospective comparative study of Selective internal radiotherapy (SIRT) and chemosaturation-percutaneous hepatic perfusion (CS-PHP) utilizing CHEMOSAT® for liver targeted therapy of patients with metastasized uveal melanoma.
August 29, 2023 | 12:25 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Delcath Systems' announcement of the presentation at the CIRSE Annual Meeting could potentially increase investor interest and confidence in the company's oncology treatments.
The presentation at a prestigious conference like CIRSE could potentially increase the visibility of Delcath Systems' oncology treatments among medical professionals and investors. This could lead to increased investor confidence and potentially a positive impact on the company's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100